Who owns Adaptimmune Therapeutics?
- Ticker: ADAPY
- CUSIP Number: 00653a107
Tip: Access positions for across all investors
Analyze quarterly positions in Adaptimmune Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Adaptimmune Therapeutics stock
Who bought or sold Adaptimmune Therapeutics this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Rhumbline Advisers | 3.7k | $72.121700 | 0% | Mar 2026 |
|
Who sold out of Adaptimmune Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Empirical Finance | Dec 2025 | 800k | $21k |
| XTX Topco | Dec 2025 | 354k | $9.2k |
| Josh Arnold Investment Consultant | Dec 2025 | 20k | $38k |
| Simplex Trading | Dec 2025 | 19k | $483.860000 |
| Acadian Asset Management | Dec 2025 | 17k | $0 |
| X-Square Capital | Dec 2025 | 11k | $0 |